Timber Creek Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-660
Closed -$116K 132
2020
Q1
$116K Sell
660
-12,448
-95% -$2.34M 0.08% 62
2019
Q4
$2.5M Sell
13,108
-10,742
-45% -$1.94M 1.5% 26
2019
Q3
$4.01M Sell
23,850
-240
-1% -$39.1K 2.57% 11
2019
Q2
$4.03M Buy
24,090
+1,518
+7% +$210K 2.6% 11
2019
Q1
$3.3M Buy
22,572
+10,915
+94% +$1.58M 2.23% 13
2018
Q4
$1.56M Sell
11,657
-26,510
-69% -$4.35M 1.21% 29
2018
Q3
$7.27M Buy
38,167
+5,180
+16% +$952K 4.69% 4
2018
Q2
$5.5M Buy
32,987
+9,740
+42% +$1.56M 3.58% 6
2018
Q1
$3.91M Buy
23,247
+19,475
+516% +$3.27M 2.47% 14
2017
Q4
$617K Sell
3,772
-14,135
-79% -$2.54M 0.39% 45
2017
Q3
$3.67M Buy
17,907
+2,085
+13% +$485K 2.47% 14
2017
Q2
$3.85M Buy
15,822
+70
+0.4% +$16.4K 2.65% 10
2017
Q1
$3.76M Buy
15,752
+122
+0.8% +$28.4K 2.83% 14
2016
Q4
$3.28M Buy
+15,630
New +$3.24M 2.56% 18

Other funds holding AGN

Timber Creek Capital Management's AGN Position: Q2 2020 in Review

Timber Creek Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 660 shares — an estimated $116K sold.

Timber Creek Capital Management first reported a position in AGN in Q4 2016 and held it in 14 quarters. The position peaked at $7.27M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Timber Creek Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Timber Creek Capital Management sold 660 Allergan plc shares in Q2 2020, an estimated $116K.
  • Timber Creek Capital Management first reported a position in Allergan plc in Q4 2016 and held it in 14 quarters.
  • Timber Creek Capital Management's Allergan plc position peaked at $7.27M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Timber Creek Capital Management's 13F filing for Q2 2020, filed 31 Jul 2020.